These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6436030)

  • 1. Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man.
    Klotz U; Ziegler G; Reimann IW
    Eur J Clin Pharmacol; 1984; 27(1):115-7. PubMed ID: 6436030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
    Klotz U; Duka T; Dorow R; Doenicke A
    Br J Clin Pharmacol; 1985 Jan; 19(1):95-8. PubMed ID: 3919752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography.
    Samson Y; Hantraye P; Baron JC; Soussaline F; Comar D; Mazière M
    Eur J Pharmacol; 1985 Apr; 110(2):247-51. PubMed ID: 2985411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and clinical use of flumazenil (Ro 15-1788).
    Klotz U; Kanto J
    Clin Pharmacokinet; 1988 Jan; 14(1):1-12. PubMed ID: 3127102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolonged coma caused by diazepam sedation in ventilated patients. Diagnostic and therapeutic use of the benzodiazepine antagonist Ro 15-1788].
    Rapold HJ; Follath F; Scollo-Lavizzari G; Kehl O; Ritz R
    Dtsch Med Wochenschr; 1984 Mar; 109(9):340-4. PubMed ID: 6421562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788).
    Lancet; 1985 Jun; 1(8441):1324-5. PubMed ID: 2860506
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies.
    Debruyne D; Abadie P; Barre L; Albessard F; Moulin M; Zarifian E; Baron JC
    Eur J Drug Metab Pharmacokinet; 1991; 16(2):141-52. PubMed ID: 1657612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration.
    Roncari G; Ziegler WH; Guentert TW
    Br J Clin Pharmacol; 1986 Oct; 22(4):421-8. PubMed ID: 3094572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in biodistribution of [3H]Ro 15-1788 in mice by acute stress: possible changes in in vivo binding availability of brain benzodiazepine receptor.
    Inoue O; Akimoto Y; Hashimoto K; Yamasaki T
    Int J Nucl Med Biol; 1985; 12(5):369-74. PubMed ID: 3009345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions and clinical pharmacokinetics of flumazenil.
    Klotz U
    Eur J Anaesthesiol Suppl; 1988; 2():103-8. PubMed ID: 2842128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational changes in benzodiazepine receptors induced by the antagonist Ro 15-1788.
    Chiu TH; Rosenberg HC
    Mol Pharmacol; 1983 Mar; 23(2):289-94. PubMed ID: 6300640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the benzodiazepine antagonist Ro 15-1788 in plasma by high-performance liquid chromatography with UV detection.
    Timm U; Zell M
    Arzneimittelforschung; 1983; 33(3):358-62. PubMed ID: 6409127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat.
    Lister RG; Greenblatt DJ; Abernethy DR; File SE
    Brain Res; 1984 Jan; 290(1):183-6. PubMed ID: 6419985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788.
    Darragh A; Lambe R; Scully M; Brick I; O'Boyle C; Downe WW
    Lancet; 1981 Jul; 2(8236):8-10. PubMed ID: 6113428
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of visual function in healthy subjects after administration of Ro 15-1788.
    Lupolover Y; Safran AB; Desangles D; de Weisse C; Meyer JJ; Bousquet A; Assimacopoulos A
    Eur J Clin Pharmacol; 1984; 27(4):505-7. PubMed ID: 6440793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pinazepam in healthy volunteers.
    Pacifici GM; Placidi GF; Fornaro P; Gomeni R
    Int J Clin Pharmacol Res; 1983; 3(5):331-7. PubMed ID: 6147314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Ro 15-1788, a benzodiazepine antagonist, in human plasma by gas-liquid chromatography with nitrogen-phosphorus detection. Application to single-dose pharmacokinetic studies.
    Abernethy DR; Arendt RM; Lauven PM; Greenblatt DJ
    Pharmacology; 1983; 26(5):285-9. PubMed ID: 6407037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol?
    Klotz U; Ziegler G; Rosenkranz B; Mikus G
    Br J Clin Pharmacol; 1986 Nov; 22(5):513-20. PubMed ID: 3098270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation.
    Schöpf J; Laurian S; Le PK; Gaillard JM
    Pharmacopsychiatry; 1984 May; 17(3):79-83. PubMed ID: 6429677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The action of the benzodiazepine antagonist Ro 15-1788].
    Doenicke A; Suttmann H; Kapp W; Kugler J; Ebentheuer H
    Anaesthesist; 1984 Aug; 33(8):343-7. PubMed ID: 6148904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.